Single User License: $2750
Member Price: FREE
Use code SUMMER at checkout for 50% OFF
Already a member? Login to access this report free.
Report Highlights
-
The U.S. market for biocompatible materials is valued at $ 22.2 billion in 2007 and is expected to grow with a compound annual growth rate (CAGR) of 6.9% to reach $30.9 billion in 2012.
-
Tissue replacements constitute the largest segment with a value of nearly $11.7 billion in 2007. This represents 52% of the total biomaterials market value. The tissue replacements will grow at a CAGR of 6.6% to reach over $16 billion in 2012.
-
The smallest segment of the biomaterials market is biocompatible surface coatings with a value of $2.6 billion in 2007. This segment is expected to grow with a CAGR of 5.7% to $3.4 billion by 2012.
INTRODUCTION
A biocompatible material or a biomaterial is any natural or synthetic substance that incorporates or integrates into a patient's body. The role of the biomaterial may be to perform, supplement, or replace a biological function that is attenuated or lost.
The goal of this report is to assess the current market for biocompatible materials including medical devices, tissue replacements, and surface coatings.
This report provides a complete overview of recent developments in each major sector of the biomaterials market. It also outlines the significant medical applications of each technology; the major market players; recent patents; and emerging technologies in implantable medical devices, advanced tissue replacements, and biocompatible surface coatings.
SCOPE OF STUDY
This report contains:
- An examination of the supporting products that have enhanced imaging at the chemical level (reagents and contrast media) and at the analysis level (software tools and image management)
- The U.S. markets for medical devices, tissue replacements, and surface coating biomaterials for a variety of biomaterials categories including metals, ceramics, polymers, and natural materials
- Assessment of the market for specific medical applications including orthopedic surgery, cardiovascular surgery and care, wound management, dentistry, urology, gastrointestinal surgery, ophthalmic care as well as plastics and reconstructive surgery
- A review of important technology and a discussion of patents in the past few decades
- Profiles of all the major companies in the industry.
INFORMATION SOURCES
This report has been assembled following an in-depth analysis of primary and secondary data. Primary research was conducted via telephone interviews with industry professionals, research scientists, physician-researchers, and laboratory heads to discover the most recent developments in their fields of interest. Secondary data was collected via a comprehensive search of the scientific, peer-reviewed literature, clinical trial reports and databases, industry trade media, company websites, annual reports, and industry press releases.
The market assessments provided have been assembled based on publicly available information from January 2002 up to and including 2007-01-15. The base year for this report is 2007 and forecast data are provided through 2012. In many cases, figures for 2006 were not yet released and in these cases figures were extrapolated from 2006 statistics, first quarter projections for 2007, and historical trends between 2002 and 2007. Market figures are based on current (2007) dollars and inflation is not computed into the projection figures.
ANALYST'S CREDENTIALS
Amy Brock, Ph.D. has over 10 years of research experience working at the interface of the biological sciences, bioengineering, and biophysics. Trained at the Massachusetts Institute of Technology and Harvard University, she holds a B.S. and Ph.D. in biomedical science. She is the author of Pharmacogenomics: New Technologies in the Development of Personalized Therapies, Kinase Inhibitors and Genetic Diseases and Medical Imaging.
Report Highlights
-
The U.S. biocompatibles market in 2003 is expected to reach $8.2 billion in sales
-
This market will grow at a 7.7% AAGR (average annual growth rate) through 2008 to reach $11.9 billion.
-
Polymer consumption, of which 80% are PVCs, will grow at a 7.9% AAGR.
-
Titanium, stainless steel and other metals will reach $212.8 million in 2008.
-
Nanotechnology is expected to yield new drug delivery products, sensors and high-performance biocompatible materials that will allow "smart" rejection resistant implants.
Related Reports
Recent Reports
Microelectronic Medical Implants: Products, Technologies & Opportunities
The global market for microelectronic medical implants is expected to grow from $49.0 billion in 2024 and is projected to reach $85.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.7% during the forecast period of 2024 to 2029.
Wearable Medical Devices: Technologies and Global Markets
The global market for wearable medical devices was valued at $35.6 billion in 2023. This market is estimated to grow from $45.0 billion in 2024 to $151.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.5% from 2024 through 2029.
Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets
The global market for radiation therapy products and radiopharmaceuticals is expected to grow from $17.5 billion in 2024 and is projected to reach $31.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2029.
Routine Health Screening Market
The global market for routine health screening is expected to grow from $59.7 billion in 2024 and is projected to reach $82.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2024 to 2029.
Elder Care Services and Assistive Devices: Global Markets
The global market for elder care services and assistive devices is expected to grow from $868.2 billion in 2024 and is projected to reach $1.1 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 5.8% during the forecast period of 2024 to 2029.
Top Trending Reports
Life Science Tools and Reagents: Global Markets
The global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.
Wearable Medical Devices: Technologies and Global Markets
The global market for wearable medical devices was valued at $35.6 billion in 2023. This market is estimated to grow from $45.0 billion in 2024 to $151.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.5% from 2024 through 2029.
Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets
The global market for radiation therapy products and radiopharmaceuticals is expected to grow from $17.5 billion in 2024 and is projected to reach $31.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2029.
Biodegradable Polymers: Global Markets and Technologies
The global market volumes of biodegradable polymers is expected to grow from 1,286.0 kilotons in 2023 and is projected to reach 4,140.0 kilotons by the end of 2028, at a compound annual growth rate (CAGR) of 26.3% during the forecast period of 2023 to 2028.
Carbon Credits Market: Global Outlook
This report provides an up-to-date analysis of current and future markets for carbon credits and the carbon offsets industry. It presents a thorough and up-to-date global assessment of the market and business of carbon credits. The report also includes a competitive landscape, ESG analysis, and detailed company profiles of leading market players.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More